Synlogic News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.04.19	Synlogic to Present Data from New Solid Oral Formulation Process at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) (Businesswire)
09.04.19	Synlogic Appoints Scott Plevy M.D. as Chief Scientific Officer (Businesswire)
02.04.19	Synlogic to Webcast Presentation at the 18th Annual Needham Healthcare Conference (Businesswire)
13.03.19	Synlogic to Webcast Presentation at the Oppenheimer 29th Annual Healthcare Conference (Businesswire)
12.03.19	Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update (Businesswire)
10.03.19	Ausblick: Synlogic stellt Zahlen zum jüngsten Quartal vor (finanzen.net)
06.03.19	Synlogic Announces Achievement of Milestone in Collaboration to Develop Synthetic Biotic™ Medicines to Treat Inflammatory Bowel Disease (Businesswire)
05.03.19	Synlogic Announces Fourth Quarter and Full Year 2018 Conference Call and Webcast (Businesswire)
28.02.19	Synlogic to Present at Investor Conferences in March (Businesswire)
20.02.19	Synlogic to Webcast Presentation at the SVB Leerink 8th Annual Global Healthcare Conference (Businesswire)
12.02.19	Synlogic Appoints Patricia N. Hurter, Ph.D. to Board of Directors (Businesswire)
03.01.19	Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts (Businesswire)
20.11.18	Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference (Businesswire)
15.11.18	IMMY Turning Heads, HSM Awaits Phase 3 Data This Year, LQDA On Watch (RTTNews)
13.11.18	Synlogic Reports Third Quarter 2018 Financial Results and Provides Program Updates (Businesswire)
12.11.18	Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) (Businesswire)
11.11.18	Ausblick: Synlogic öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
07.11.18	Synlogic Announces Third Quarter 2018 Conference Call and Webcast (Businesswire)
06.11.18	Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting (Businesswire)
01.11.18	Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting (Businesswire)
02.10.18	Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer (Businesswire)
25.09.18	Synlogic to Webcast Presentation at the Leerink Partners Roundtable Series: Rare Disease & Oncology (Businesswire)
29.08.18	Synlogic to Webcast Presentation at the H. C. Wainwright 20th Annual Global Investment Conference (Businesswire)
13.08.18	Synlogic Publishes Preclinical Data Supporting Development of SYNB1618, a Synthetic Biotic™ Medicine as a Potential Treatment for Phenylketonuria (Businesswire)
08.08.18	Synlogic Reports Second Quarter 2018 Financial Results and Provides Program Updates (Businesswire)
07.08.18	Synlogic to Webcast Presentation at the 2018 Wedbush PacGrow Healthcare Conference (Businesswire)
25.06.18	Synlogic Presents New Preclinical Data from Synthetic Biotic™ Immuno-Oncology Program at FOCIS 2018 (Businesswire)
25.06.18	Synlogic Joins Russell 3000® Index (Businesswire)
11.06.18	Synlogic Presents Preclinical Data from Synthetic BioticTM Medicine, SYNB1618, for the Treatment of Phenylketonuria (Businesswire)
15.05.18	Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update (Businesswire)
10.05.18	Synlogic Announces Leadership Change (Businesswire)
25.04.18	Synlogic Receives Fast-Track Designation for SYNB1618, a Synthetic Biotic™ medicine for the Treatment of Phenylketonuria (Businesswire)
18.04.18	Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria (Businesswire)
16.04.18	Synlogic Presents Preclinical Data from Synthetic Biotic Immuno-Oncology Program at the American Association for Cancer Research 2018 Annual Meeting (Businesswire)
06.04.18	Synlogic Announces Registered Direct Offering of Common Stock (Businesswire)
02.04.18	Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with Cirrhosis (Businesswire)
21.03.18	Synlogic to Present at the 17th Annual Needham Healthcare Conference (Businesswire)
20.03.18	Synlogic Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update (Businesswire)
19.03.18	Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting (Businesswire)
05.03.18	Synlogic to Webcast Presentation at the Cowen and Company 38th Annual Health Care Conference (Businesswire)
04.03.18	An Ear To The Pharma: 7 Stocks To Watch This Week (RTTNews)
13.02.18	Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic™ Medicine (Businesswire)
08.02.18	Synlogic to Present at the Leerink Partners 7th Annual Global Healthcare Conference (Businesswire)
24.01.18	Synlogic Announces Pricing of Public Offering of Common Stock (Businesswire)
23.01.18	Synlogic Announces Proposed Public Offering of Common Stock (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Synlogic Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten